|
HS Code |
795222 |
| Name | Articaine Hydrochloride |
| Chemical Formula | C13H20N2O3S·HCl |
| Molecular Weight | 320.84 g/mol |
| Appearance | White crystalline powder |
| Solubility | Freely soluble in water |
| Ph Range | 4.0–5.0 (in solution) |
| Melting Point | 170-174°C (decomposes) |
| Cas Number | 23964-57-0 |
| Route Of Administration | Injection (local anesthesia) |
| Atc Code | N01BB58 |
| Mechanism Of Action | Blocks sodium channels, inhibiting nerve impulse conduction |
| Indications | Local dental anesthesia |
| Storage Temperature | Below 25°C (77°F) |
| Protein Binding | Approximately 95% |
| Half Life | About 20-30 minutes |
As an accredited Articaine Hydrochloride factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Articaine Hydrochloride packaging: Sterile, sealed box containing 50 x 1.7 mL glass cartridges, labeled with concentration, batch number, and expiry date. |
| Shipping | Articaine Hydrochloride is shipped in tightly sealed, labeled containers to ensure stability and prevent contamination. It is transported under controlled temperature conditions, typically at room temperature, avoiding excessive heat or moisture. All packaging complies with regulatory and safety guidelines for hazardous chemicals, ensuring secure and compliant delivery to the destination. |
| Storage | Articaine Hydrochloride should be stored in a tightly closed container at controlled room temperature, typically between 20°C and 25°C (68°F and 77°F), away from light and moisture. It should be kept in a well-ventilated area, separate from incompatible substances, and out of reach of unauthorized personnel and children. Avoid freezing and protect from excessive heat. |
|
Purity 99%: Articaine Hydrochloride with 99% purity is used in dental local anesthesia procedures, where it ensures rapid onset and reliable nerve blockage. Melting point 162°C: Articaine Hydrochloride with a melting point of 162°C is used in surgical infiltration anesthesia, where it provides thermal stability during sterilization. Particle size <10 microns: Articaine Hydrochloride with particle size less than 10 microns is used in injectable formulations, where it achieves optimal dispersion and uniform absorption. Aqueous solubility 40 mg/mL: Articaine Hydrochloride with aqueous solubility of 40 mg/mL is used in clinical dental injections, where it allows for high-concentration preparations and effective analgesia. Stability temperature up to 25°C: Articaine Hydrochloride stable up to 25°C is used in pharmaceutical storage, where it maintains potency and chemical integrity during shelf life. Enantiomeric excess >98%: Articaine Hydrochloride with enantiomeric excess greater than 98% is used in nerve block anesthesia, where it minimizes side effects associated with chiral impurities. pH 4.0-5.0: Articaine Hydrochloride formulated at pH 4.0-5.0 is used in medical injections, where it reduces the risk of tissue irritation at the administration site. Low endotoxin level <0.25 EU/mg: Articaine Hydrochloride with low endotoxin level less than 0.25 EU/mg is used in sensitive surgical anesthesia, where it decreases the likelihood of pyrogenic reactions. Viscosity grade suitable for injection: Articaine Hydrochloride with injectable-grade viscosity is used in maxillofacial surgery anesthesia, where it ensures smooth administration and patient comfort. |
Competitive Articaine Hydrochloride prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Articaine Hydrochloride brings something fresh to the dental chair. Over the years, I’ve watched countless types of anesthetics claim the spotlight, each promising smoother procedures and quicker patient recovery. But Articaine Hydrochloride, especially in its common 4% solution with 1:100,000 epinephrine, lives up to its reputation by balancing rapid onset with reliable strength. The difference stands out most during those procedures where a simple lidocaine shot falls short. As a dental patient myself, the feeling is hard to ignore. With Articaine, the numbness sets in almost before the dentist is done prepping the syringe, and the wake-up call is gentle, never abrupt.
Articaine Hydrochloride doesn't just ride on tradition—it answers specific needs. Here you get an amide local anesthetic with a unique thiophene ring, which stands apart from lidocaine’s usual benzene structure. This subtle chemical twist turns into a real-world advantage. The drug’s molecules fit closer into your nerve cells, which shows in the quick action you feel at the dentist. Studies, including those published in peer-reviewed journals, indicate that Articaine clocks a faster onset—about 1 to 3 minutes for infiltration—making it a handy pick for demanding dental surgeries and root canal sessions.
My colleagues often debate which anesthetic handles stubborn bone tissue best. Articaine seems to gain the upper hand, especially during infiltrations in the posterior mandible, an infamously tough spot. Research suggests this makes Articaine a smarter pick for procedures in dense bone areas, where lidocaine sometimes leaves patients flinching. Reports in journals like the Journal of the American Dental Association and numerous clinical studies back up these field experiences, pointing to higher success rates in certain techniques.
Looking beyond the lab, Articaine Hydrochloride’s performance plays out daily in millions of dental clinics. Dentists see fewer failed blocks and less patient anxiety. Patients might not know the science behind it, but they remember the shorter, less stressful appointments. The drug gets credit for letting dental professionals work faster and safer, with less need to reload and re-inject. In pediatric cases, where children often dread long procedures, Articaine makes the experience more manageable for both sides.
Reviewing how Articaine fits into current dental care, it’s clear the compound isn’t just another name on a product list. It reshapes expectations around local anesthesia in routine fillings, extractions, and root canals. Where older agents might stumble, Articaine often carries patients through comfortably. The ability to handle both soft and hard tissues with minimal diffusions into the bloodstream gives it a practical edge. Its use has grown globally, and the anecdotal evidence lines up with the research: reduced pain, better control, and a much smoother recovery process.
Most manufacturers market Articaine as a 4% injectable solution, commonly paired with 1:100,000 or 1:200,000 epinephrine. The adrenaline keeps blood loss to a minimum, and prolongs numbness in a predictable, adjustable way. The vials come in classic 2 mL cartridges, perfect for efficient use in fast-paced dental settings. Every milliliter contains 40 milligrams of Articaine, carefully balanced to reduce risk while boosting effectiveness.
Thanks to its chemical design, Articaine works quickly and leaves the scene in good time. A quick half-life—roughly 20 minutes in plasma—means patients feel less linger, less grogginess post-procedure. Metabolism happens mainly in the blood through plasma esterases, quite different from other amide anesthetics that rely on the liver. For patients with liver compromise, dentists can opt for Articaine with a bit more confidence. Safety matters. The rates of allergic reactions remain low, and for most healthy adults, the recommended maximum daily dose sits around 7 mg per kilogram without reaching the ceiling too quickly. Rare side effects exist, as with any medication, but the safety profile matches—or even improves on—older anesthetics.
Every anesthetic comes with its own playbook. In practical use, Articaine shines because it adapts to both routine and complex dental procedures. Where lidocaine and mepivacaine have a hard time settling into dense bone, Articaine slips in almost effortlessly. The quick onset means less fidgeting in the chair. Recovery times, both in terms of tissue numbness and clarity of speech, seem to satisfy patients far better.
I've worked with children and adults who remember the difference. Articaine seems to leave a smaller footprint once the dental work wraps up. There's less of that puffy, swollen face that lingers with other anesthetics. People walk out able to chat, eat, and return to their day without the odd numbness creeping into their cheeks for hours.
Concerns do get raised, especially about nerve injuries or paresthesia reports. Some studies note a slightly higher incidence of long-term numbness with Articaine in certain nerve blocks, especially in third molar extractions. Broad clinical reviews, though, suggest most cases clear up within weeks, and the major consensus keeps Articaine in the safe, effective, and reliable camp. Weighing the benefit of faster numbness with the small risk of persistent numbness, most dentists value the predictability Articaine offers.
Practitioners see Articaine as a go-to for both complex and straightforward dental work. Temporary crowns, fillings, and extractions take less out of the patient. Surgical procedures turn less daunting, even with tricky anatomy or past failed blocks. For example, during pediatric treatments that demand fast, friendly injections, Articaine makes it easier for children to cope. Data also suggest its effectiveness in infection sites, where acidic tissue can hinder traditional amide anesthetics.
For medical staff, Articaine saves time. Shortened onset translates directly to fewer interrupted sessions and smoother workflow. Fewer failed injections mean less patient stress—something that isn't easy to measure but always obvious in the waiting room. In busy community clinics, minimizing repeat appointments makes a difference to both patient morale and the economic bottom line. The more reliable anesthetic, the better reputation follows, and trust in the practice grows.
On the patient side, people who’ve had uncomfortable experiences with older anesthetics often notice the difference right away. There’s a reduction in that heavy, pillow-like sensation that drags through the jaw for the rest of the afternoon. I’ve watched patients glance at their phone, surprised at the short time passed since the injection. This isn’t just comfort—it’s convenience. Busy parents, workers needing a quick lunchtime visit, even elderly patients with medical complexities all value a smoother recovery.
Ask most dentists about local anesthetics, and a few names come up right away: lidocaine, mepivacaine, prilocaine, and more recently, Articaine Hydrochloride. The main contrast draws out in speed, depth, and duration. Lidocaine remains a classic for its familiarity, but it doesn’t always cut it for lower jaw infiltration. Mepivacaine helps where patients can’t take epinephrine, but its track record in complex cases leaves some wishing for more.
Articaine Hydrochloride’s chemical make-up brings higher lipid solubility, which translates into easier movement through nerve tissue. This is a game-changer, especially in areas with tough bone or unusual nerve patterns. It grabs a spot among the top choices for those tough injections where the jawbone resists standard solutions. A higher concentration means less volume is needed, keeping swelling and tissue trauma to a minimum.
Another point of difference lies in metabolism. While most amide anesthetics depend on the liver, increasing risk for patients with hepatic conditions, Articaine gets quickly hydrolyzed in the plasma. This feature reassures both dentist and patient when systemic clearance is a concern, whether for liver-compromised patients or those with certain drug interactions. Articaine’s lower systemic toxicity and brief half-life remove much of the worry around lingering numbness, and help avoid those afternoon slumps after a long dental appointment.
Some drawbacks exist. Reports of nerve injuries, particularly following inferior alveolar nerve blocks, steer some practitioners toward alternative agents for these specific injections. Direct needle trauma, rather than the drug alone, appears to be the leading culprit. But the evidence from large clinical cohorts shows Articaine’s risk profile sits in line with comparable anesthetic agents when used according to recommended protocols.
Demand for Articaine keeps rising for good reasons. Today’s dental landscape expects efficiency, quick turnover, and happier patients. The anesthetic delivers on these fronts. Dentists move through more appointments without rushing. Patients return to their lives with less downtime. Insurance companies and clinics appreciate the streamlined workflow and fewer follow-up visits.
For populations outside of large urban hospitals—think of rural clinics or mobile dental vans—Articaine’s ease of use and reliable results matter even more. Far from backup resources and specialist consults, the dependable anesthetic makes both routine and after-hours care less intimidating for both provider and patient. Its shelf stability and compact vial size simplify inventory and reduce waste, keeping costs better controlled.
No drug escapes scrutiny, especially as more data emerge. Paresthesia, or numbness lasting past the procedure, surfaces in some reviews. Critics have asked if higher concentrations in Articaine—the standard 4% versus 2% in lidocaine—raises this risk. Subsequent studies, though, including those from regulatory bodies and dental associations, indicate that the actual cause rests mostly on injection technique, needle size, and nerve proximity, rather than the chemical itself.
The real solution points toward better training: focusing on gentle, precise injection technique, patient history, and clear communication about risks and expectations. Clinics investing in continuing education for dental professionals see marked declines in complaints related to nerve issues, with patient-reported satisfaction holding steady or improving. Manufacturers also continue working on refining formulation and cartridge design to lower possible trauma on injection.
While dentistry claims the largest slice of Articaine use, it finds work in other medical environments as well—minor dermatological procedures, wound cleaning, small surgical extractions—anywhere rapid, reliable nerve block is valued. Its short action means doctors can perform quick interventions without committing patients to extended numbness.
Regulatory agencies such as the FDA, European Medicines Agency, and similar bodies in Asia-Pacific countries monitor Articaine closely. Wide regulatory approval across these regions speaks to the compound’s safety record. Still, medical professionals stay alert to any flagged trends from post-market surveillance and published literature, staying ahead of new challenges as they arise.
The story of Articaine Hydrochloride reflects the larger evolution of healthcare—drugs move past mere compliance and into the realm of patient-centered care. The compound embodies a mix of research-driven confidence and daily workhorse reliability. Dentists, patients, and clinics count on it not just because it’s new, but because experience and evidence line up behind it.
For those in the dental field, it’s never enough to simply use the newest available tool. Success with Articaine, like with any anesthetic, depends on understanding the right context: case selection, patient health, and proper injection. Staying informed—reading new research, sharing outcomes in local study clubs, listening to patient feedback—keeps standards high. The dental and broader medical communities grow by building on lessons learned, not by chasing novelty.
For patients heading to the dentist and hearing about Articaine, reassurance comes from knowing it’s a well-researched and broadly used choice. Explaining its quick action and fast recovery helps reduce appointment-day nerves. People with allergies to other anesthetics, liver concerns, or tough-to-numb bone structures often benefit directly from Articaine. For those worried about lingering numbness or rare nerve issues, open conversation with the provider matters most. Dentists can outline the reasons for choosing this anesthetic and address any personal medical concerns before the work starts.
For dental and medical professionals, the lesson from Articaine’s popularity lies in critical evaluation. Just because a product performs better on paper doesn’t guarantee it’s right for every patient. Most practitioners keep several anesthetic options on hand—each with their own dosages, strengths, and application protocols. The ability to match the right agent to the clinical situation builds confidence for every visit.
Continuing education remains the foundation for safe, effective Articaine use. Hands-on workshops, seminars, and case studies deepen familiarity. Practitioners thrive by sharing both successes and occasional failures, reinforcing what works and what needs a second look. Taking patient feedback seriously, adjusting technique, and learning from updated guidelines all help maintain professional trust.
Modern research around Articaine Hydrochloride doesn’t rest. Teams look for improved delivery methods, such as computer-assisted anesthesia systems, and explore using smaller needles to cut down on tissue trauma. Researchers also explore how the drug interacts with other medications or emerging dental technologies like laser dentistry and 3D imaging. Each breakthrough moves the experience closer to the ideal of pain-free, low-risk outpatient care.
There’s a broader conversation about how to balance safety and innovation. Health agencies encourage post-market surveillance, gathering real-world data from diverse patient populations—not just clinical trial volunteers. This feedback loop keeps both providers and the public in the know about what works, what doesn’t, and which new complications arise as use grows. Practitioners who contribute to this flow of information help raise the bar for everyone, from large academic centers to small-town clinics.
Articaine Hydrochloride already secures its place as a mainstay in dental and minor medical procedures. Changing technology, patient demographics, and expectations will push further innovations. The core value remains—faster, more comfortable procedures and improved patient outcomes. For providers, families, and policymakers, the drug presents a chance to rethink standard practices, invite better feedback, and set a new baseline of care.
Years from now, the conversation may shift to newer agents or delivery systems, but Articaine’s legacy will likely remain as the anesthetic that made dental visits safer, smoother, and less daunting. Each successful appointment, comfortable recovery, and patient smile gives this compound its staying power—and reminds everyone involved that careful progress, not blind tradition, moves medicine forward.